Mesalazine Drug Classification
Mesalazine (mesalamine) is a 5-aminosalicylic acid (5-ASA) compound, which belongs to the aminosalicylate class of anti-inflammatory medications. 1
Chemical and Pharmacological Classification
Mesalazine is chemically known as 5-amino-2-hydroxybenzoic acid with the empirical formula C7H7NO3 2. While it is structurally related to salicylates and is sometimes classified as a nonsteroidal anti-inflammatory drug (NSAID) 3, its primary classification in clinical practice is as an aminosalicylate or 5-ASA compound 1.
Clinical Context
The 5-ASA class represents the mainstay of therapy for mild-to-moderate ulcerative colitis 1. This class includes:
- Mesalamine (pure 5-ASA in various formulations)
- Sulfasalazine (5-ASA bonded to sulfapyridine)
- Diazo-bonded 5-ASAs (balsalazide and olsalazine - prodrugs converted to 5-ASA in the colon) 1
Mechanism of Action
The 5-ASA moiety is believed to be the active compound for treatment of ulcerative colitis, exerting a topical anti-inflammatory effect on colonic epithelial cells 2. It appears to work by blocking cyclooxygenase and inhibiting prostaglandin production in the colon, though the mechanism is not fully understood 2.
Key Clinical Point
When discussing mesalazine in medical documentation or prescribing, it should be referred to as a 5-aminosalicylate (5-ASA) or aminosalicylate, not simply as an NSAID, as this more accurately reflects its therapeutic class and clinical use in inflammatory bowel disease 1.